| Drug Eluting Stents are used for the treatment of | | | | viable treatment. Moreover, the growth is fueled |
| heart patients to prevent the need for | | | | by the robust economic growth and a greater |
| more-invasive procedures, such as coronary | | | | adoption of social security schemes in the Asian |
| artery bypass surgery. This reduces the need for | | | | regions. There are a large number of patients |
| repeated hospitalization and angioplasty | | | | opting for these treatments so as to enhance |
| procedures, thus reducing risks due to | | | | their quality of life. Further, developed countries |
| complications such as heart attack and stroke. | | | | provide easy reimbursement options for |
| The Global Drug Eluting Stent market has been | | | | higher-priced Drug Eluting Stent, which makes |
| registering a significant growth in the recent past. | | | | them affordable for patients. Moreover |
| This market is witnessing a consolidation of major | | | | reimbursements by national medical savings |
| players through strategic alliances. Moreover, the | | | | schemes play a crucial role in the demand for the |
| Drug Eluting Stent providers are looking forward | | | | Drug Eluting Stents. |
| to expand their product portfolio to provide a full | | | | The report by TechNavio Insights forecasts the |
| range of interventional therapies to the physicians | | | | drug eluting stents market size of the over the |
| and patients. | | | | period 2008-2012. Further, it discusses the |
| The growth in the demand for the Drug Eluting | | | | segmentation of the drug eluting stents market |
| Stent is due to its increasing acceptance as a | | | | into various geographic regions. |